Next Article in Journal
Regulation of mTOR, Metabolic Fitness, and Effector Functions by Cytokines in Natural Killer Cells
Next Article in Special Issue
The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas
Previous Article in Journal
Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame
Previous Article in Special Issue
EMT and Treatment Resistance in Pancreatic Cancer
Open AccessFeature PaperReview

The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis

Department of Human and Molecular Genetics, VCU Institute of Molecular Medicine, VCU Massey Cancer Center, School of Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Joëlle Roche
Cancers 2017, 9(10), 131; https://doi.org/10.3390/cancers9100131
Received: 7 September 2017 / Revised: 22 September 2017 / Accepted: 25 September 2017 / Published: 27 September 2017
(This article belongs to the Special Issue The Epithelial-to-Mesenchymal Transition (EMT) in Cancer)
Polo-like kinase 1 (PLK1) is a serine/threonine kinase that plays a key role in the regulation of the cell cycle. PLK1 is overexpressed in a variety of human tumors, and its expression level often correlates with increased cellular proliferation and poor prognosis in cancer patients. It has been suggested that PLK1 controls cancer development through multiple mechanisms that include canonical regulation of mitosis and cytokinesis, modulation of DNA replication, and cell survival. However, emerging evidence suggests novel and previously unanticipated roles for PLK1 during tumor development. In this review, we will summarize the recent advancements in our understanding of the oncogenic functions of PLK1, with a focus on its role in epithelial-mesenchymal transition and tumor invasion. We will further discuss the therapeutic potential of these functions. View Full-Text
Keywords: PLK1; EMT; tumor invasion and metastasis; drug resistance; cancer therapy PLK1; EMT; tumor invasion and metastasis; drug resistance; cancer therapy
Show Figures

Figure 1

MDPI and ACS Style

Fu, Z.; Wen, D. The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis. Cancers 2017, 9, 131.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop